Source:http://linkedlifedata.com/resource/pubmed/id/11839442
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2002-2-12
|
pubmed:abstractText |
The aim of this study was to determine the intestinal absorption characteristics of the antiviral agent UC-781 and to optimize the experimental conditions of the in vitro system for low solubility compounds. The absorption potential of UC-781 was studied with the Caco-2 system and with the rat intestinal perfusion technique. The low solubility of UC-781 required the use of solubility/dissolution rate enhancing agents (e.g. VitE-TPGS, Gelucire 44/14). The creation of sink conditions in the receiver compartment of the Caco-2 system was a prerequisite to reliably study the transport of this poorly soluble compound. After inclusion of VitE-TPGS in the acceptor solution, UC-781 could be characterized as a class II drug of the Biopharmaceutical Classification System (low solubility, high permeation across membranes). A significant concentration-dependent decrease in transport of UC-781 was observed upon increasing the concentration of VitE-TPGS in the apical compartment. This observation contrasts to the absorption enhancing properties of VitE-TPGS, and can probably be attributed to a decrease in the concentration of free UC-781 when using higher concentrations of the solubility/dissolution rate enhancing agents. The use of Gelucire 44/14 as a solubilizing agent resulted in a batch-dependent degradation of UC-781. The inclusion of the solubility/dissolution rate-enhancing agent VitE-TPGS did not result in absorption enhancement in the intestinal perfusion technique.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0378-5173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
234
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11839442-Anilides,
pubmed-meshheading:11839442-Animals,
pubmed-meshheading:11839442-Biological Transport,
pubmed-meshheading:11839442-Caco-2 Cells,
pubmed-meshheading:11839442-Chromatography, High Pressure Liquid,
pubmed-meshheading:11839442-Drug Delivery Systems,
pubmed-meshheading:11839442-Furans,
pubmed-meshheading:11839442-Humans,
pubmed-meshheading:11839442-Intestinal Absorption,
pubmed-meshheading:11839442-Male,
pubmed-meshheading:11839442-Microdialysis,
pubmed-meshheading:11839442-Perfusion,
pubmed-meshheading:11839442-Rats,
pubmed-meshheading:11839442-Rats, Wistar,
pubmed-meshheading:11839442-Reverse Transcriptase Inhibitors,
pubmed-meshheading:11839442-Solubility,
pubmed-meshheading:11839442-Spectrophotometry, Ultraviolet
|
pubmed:year |
2002
|
pubmed:articleTitle |
Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781.
|
pubmed:affiliation |
Laboratory of Pharmacotechnology and Biopharmacy, Katholieke Universiteit Leuven, O&N, Gasthuisberg, 3000 Leuven, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|